Because many enteroviruses are restricted by type I IFN signaling in small animal models and because we have previously shown that E11 is sensitive to recombinant IFN-β treatment [24], we reasoned that type I IFNs might play a key role in restricting E11 infection in vivo. Here, IFNB1 is linked to infection.